Trial Profile
XELODA metronomic in patients with advanced hepatocellular carcinoma and functionality liver child-pugh B.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2014
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms EPAX
- 16 Jul 2014 New trial record